ESTABLISHED 2021 · HONG KONG SAR

About Asaptic — A Hong Kong Medical Device & Components Sourcing Company

HK-incorporated principal-reseller of certified industrial and clinical components, connecting verified Chinese factories to Western B2B buyers.

Asaptic (HK) Ltd was incorporated in Hong Kong in July 2021 and has operated continuously since. We are a Hong Kong medical device sourcing company acting as principal-reseller of certified medical devices and deep-tech components — not a broker or intermediary. We are the commercial counterparty on every transaction. Our pipeline is approximately 99% AI-operated, with human review on every outgoing commitment.

Incorporated

July 2021, Hong Kong SAR

Structure

Private limited company

CR Number

Available on request

Operations

AI-operated ~99% autonomous; sole human principal reviews every outgoing commitment

Capital

Not raising capital

Factory-direct sourcing. Principal economics. Full compliance packages.

Source certified factory products for Western B2B buyers
Act as principal & counterparty — not a broker or agent
Provide full compliance document packages with every shipment

Principal-reseller. Deposit-first economics. AI-operated pipeline.

Three structural properties that define how Asaptic operates — and why they matter to buyers evaluating a new sourcing counterparty.

PRINCIPAL-RESELLER

We are the commercial counterparty, not a middleman.

Asaptic takes title to goods and acts as the seller of record on every transaction. This means your contract is with Asaptic — not an unnamed factory. Liability, warranty, and compliance obligations sit with us, not passed through to an upstream party you have no visibility into. We source from verified factories and stand behind the product, including clinical device sourcing with full compliance documentation. This is a structurally different relationship from freight brokers, trading agencies, or commission-based sourcing agents.

Deposit-First Economics

30% proforma invoice reserves your production slot; balance is settled against bill of lading. Near-zero working capital exposure for Asaptic. This is the same payment mechanism used by large buying groups and is a standard feature of factory-direct trade — not a sign of counterparty risk. See our sourcing process for a step-by-step walkthrough.

AI-Operated Pipeline (~99% autonomous)

Quotation, supplier qualification research, compliance document assembly, and correspondence are handled by AI. This means faster quotes, more thorough documentation, and 24/7 responsiveness. Every outgoing commitment — purchase order confirmation, PI issuance, contract signature — receives human review before dispatch. Ready to start? Engage with us to open a sourcing inquiry.

Grounded in Asia-Pacific operations, Hong Kong law, and an established trade network.

Asaptic's sourcing relationships and market access are informed by operational adjacency — not theoretical positioning.

Affiliated with established Asia-Pacific clinical-nutrition operations, providing sourcing adjacency and market-access context for hospital and aged-care channels in Canada and Australia.

Member of the HKSTP network.

Operating context: Hong Kong SAR — common law jurisdiction, widely recognised for trade finance, letter of credit enforcement, and international contract dispute resolution.

Clinical-Nutrition Adjacency

Affiliated Asia-Pacific operations provide market-access context for hospital and aged-care procurement in Canada and Australia — channels that inform our component qualification standards.

HKSTP Network

Member of the Hong Kong Science and Technology Parks Corporation network, supporting access to deep-tech manufacturers and advanced component suppliers.

Common Law Jurisdiction

Hong Kong SAR offers internationally recognised contract enforcement, trade finance infrastructure, and a stable regulatory environment familiar to Western buyers.

Factory Access

Direct relationships with verified Chinese manufacturers across medical devices, precision components, and deep-tech hardware — built through repeated transaction history, not directory listings.

What Asaptic does not do.

Clarity on scope saves time for both parties. If your requirement falls outside these boundaries, we will say so at first contact rather than after extended qualification.

B2B ONLY

No consumer goods. No retail. No direct-to-consumer fulfilment.

Asaptic operates exclusively in business-to-business supply chains. Our minimum engagement is a commercial purchase order with a qualified business buyer. We do not supply individuals, do not list on consumer marketplaces, and do not provide fulfilment services for retail inventory. If your buying entity is a registered business with a genuine procurement requirement, you are in scope.

No Unverified Factory Brokering

We do not pass buyer RFQs to an open pool of unvetted suppliers and take a commission on whatever responds. Every factory in our pipeline has been qualified through direct engagement, transaction history, or an on-the-ground audit process.

Not Raising Capital

Asaptic is not seeking investment, does not have an open funding round, and is not interested in unsolicited investor introductions. Our operating model is designed around trade economics, not venture capital.

Affiliated Ventures — Disclosed on Request

Asaptic does not name affiliated ventures or related operating entities publicly. Details are disclosed under a signed commercial engagement or NDA. Inquiries can be directed to [email protected].

Engage with Asaptic

For sourcing inquiries, include your component category, destination market, target volume, and timeline. We respond within four hours on business days. For compliance or entity questions, include as much context as you can — we will respond directly and without a sales funnel.

Contact us →